Roche sales and marketing update

ROCZ launched MabThera to treat non-Hodgkin's lymphoma (NHL) in Japan. MabThera was discovered by Idec Pharmaceuticals Corp. (IDPH, San Diego, Calif.) and is marketed in the U.S. by IDPH and partner ...